These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2387550)

  • 1. [Substitution therapy with antithrombin III in orthotopic liver transplantation: possible effect on hemorrhage reduction].
    Baudo F; Caimi MT; Redaelli R; Cattaneo D; De Gasperi A; Belli L; de Cataldo F
    Haematologica; 1990; 75 Suppl 2():41-9. PubMed ID: 2387550
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombin III in heart surgery: preventive clinical use of a specific concentrate].
    Pula G
    Haematologica; 1990; 75 Suppl 2():50-3. PubMed ID: 2387551
    [No Abstract]   [Full Text] [Related]  

  • 3. Recovery of antithrombin III in patients undergoing orthotopic liver transplantation after administration of an antithrombin III concentrate.
    Scherer RU; Gödde S; Giebler RM; Schmutzler MJ; Erhard J; Kox WJ
    Semin Thromb Hemost; 1993; 19(3):309-10. PubMed ID: 8362259
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of antithrombin iii concentrations during cardiopulmonary surgery].
    Sonzogni V; Bellavita P; Carrara B; Cossolini M; Ferri F; Fabretti F; Mamprin F; Pelliccioli I
    Minerva Anestesiol; 2000; 66(1-2):17-23. PubMed ID: 10736978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III replacement in orthotopic liver transplantation.
    Coccheri S; Palareti G
    Semin Thromb Hemost; 1993; 19(3):268-72. PubMed ID: 8362256
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular collapse during living-directed orthotopic liver transplantation associated with the transfusion of contaminated red blood cells.
    Nemergut EC; Mintz PD; Clark P; Sawyer RG; Pruett TL
    J Cardiothorac Vasc Anesth; 2007 Dec; 21(6):870-2. PubMed ID: 18068070
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for bleeding and transfusion during orthotopic liver transplantation.
    Roullet S; Biais M; Millas E; Revel P; Quinart A; Sztark F
    Ann Fr Anesth Reanim; 2011 Apr; 30(4):349-52. PubMed ID: 21353450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation: effect of washing bank blood on intraoperative control of hyperkalemia.
    Ellis R; Beeston JT; Witherington SS; Allen EL; Keenan RL
    Transplant Proc; 1987 Aug; 19(4 Suppl 3):73-4. PubMed ID: 3303541
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracerebral hemorrhage after liver transplantation.
    Wang WL; Yang ZF; Lo CM; Liu CL; Fan ST
    Liver Transpl; 2000 May; 6(3):345-8. PubMed ID: 10827237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatic coagulopathy--principles and therapeutic statements].
    Thaler E; Kleinberger G
    Leber Magen Darm; 1982 Oct; 12(5):193-7. PubMed ID: 7182699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic fibrinogenolysis in liver transplantation.
    Grosse H; Lobbes W; Sato M; Ringe B; Barthels M
    Transplant Proc; 1990 Oct; 22(5):2303-4. PubMed ID: 2219380
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acquired antithrombin III deficiency in cardiac surgery: an update].
    Muedra V
    Rev Esp Anestesiol Reanim; 2012; 59(7):347-9. PubMed ID: 22749326
    [No Abstract]   [Full Text] [Related]  

  • 13. Approach to the bleeding patient.
    Marengo-Rowe AJ
    Int Anesthesiol Clin; 1982; 20(4):137-56. PubMed ID: 6816739
    [No Abstract]   [Full Text] [Related]  

  • 14. Coagulation profiles and intraoperative substitution requirements during elective piggyback liver transplantation with prophylactic antifibrinolytic therapy.
    Weber T; Sendt W; Grube T; Scheele J
    Transpl Int; 2002 Jun; 15(6):310-6. PubMed ID: 12072902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood replacement in liver and pancreas/kidney transplantation].
    Rosmanith P; Schönitzer D
    Beitr Infusionsther; 1989; 24():165-71. PubMed ID: 2481534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic variables and blood loss during orthotopic human liver transplantation.
    Kratzer MA; Dieterich J; Denecke H; Knedel M
    Transplant Proc; 1991 Jun; 23(3):1906-11. PubMed ID: 2063424
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of blood product use in orthotopic liver transplantation using the piggyback hepatectomy technique.
    Mangus RS; Kinsella SB; Nobari MM; Fridell JA; Vianna RM; Ward ES; Nobari R; Tector AJ
    Transplant Proc; 2007 Dec; 39(10):3207-13. PubMed ID: 18089355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications associated with percutaneous placement of venous return cannula for venovenous bypass in adult orthotopic liver transplantation.
    Sakai T; Planinsic RM; Hilmi IA; Marsh JW
    Liver Transpl; 2007 Jul; 13(7):961-5. PubMed ID: 17600351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III, blood loss, and transfusion requirements during liver transplantation.
    Baudo F; De Gasperi A; Belli L; de Cataldo F
    Lancet; 1991 Oct; 338(8771):897-8. PubMed ID: 1681262
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of absorbable mesh in the treatment of parenchymal liver injuries during orthotopic liver transplantation.
    Soliman TH; Langer F; Puhalla H; Pokorny H; Grünberger TH; Berlakovich GA; Mühlbacher F; Steininger R
    Eur J Surg; 2001 Jan; 167(1):29-34. PubMed ID: 11213817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.